We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Risk Tolerance Focus Continues: Meeting, Patient Survey Planned
The FDA has scheduled a May 18 public meeting to gather input on how patients can more effectively influence the agency’s reviews of new medical devices, drugs and biological products.